INSVISION and 10 other major projects signed agreements and began implementation.

On the morning of July 9, Zhuhai Zhongke Innovation Science Park, a provincial-level key project with a total investment exceeding 2 billion yuan, officially began operations, accompanied by a signing ceremony for major technology transfer projects. Chen Yong, Secretary of the Municipal Party Committee and Secretary of the CPC Committee of Hengqin, attended the event.

It is understood that, As a key provincial-level project and an important innovation platform for Zhuhai to promote the commercialization of scientific and technological achievements , Total floor area Approximately 220,000 square meters Zhuhai Zhongke Innovation Science and Technology Park will soon focus on strategic deployments. Artificial intelligence, robotics, 3D machine vision, biomedical engineering, integrated circuits Such strategic emerging industries, introducing Over 100 companies High-tech enterprise, established 500–1,000 people A high-end talent cluster, designed to create "Innovation downstairs, entrepreneurship upstairs" A full-chain incubation ecosystem.

At the event venue, 11 major technology transfer projects signed and set to be implemented , injecting strong momentum into the Bay Area's innovation and tech ecosystem!

Among these initiatives, the China-Europe Innovation Center for Medicine and Health will be established within the park, aiming to achieve breakthroughs in critical areas such as the localization of gene-editing tools and the large-scale production of viral vectors—bottleneck technologies that have long posed challenges. Qiyuan Vision will leverage its core technologies—such as dynamic 3D reconstruction and high-precision recognition algorithms—to empower industrial inspection and drive the upgrade of intelligent manufacturing, accelerating the Greater Bay Area's efforts to build a globally leading R&D hub for advanced equipment. ; Zhongke Aishen Pharmaceutical Co., Ltd.'s core product has entered Phase II clinical trials and is poised to fill the gap in innovative drugs for major cardiovascular and liver diseases in China.

During an inspection of 11 major projects that have already been signed and are set to be implemented, Chen Yong, Secretary of the Zhuhai Municipal Party Committee and Secretary of the Hengqin Working Committee of the Provincial Party Committee, Focus on biomedicine, 3D machine vision, and artificial intelligence. Core technology breakthroughs and industrial applications in various fields. Qiyuan Vision CEO Xing Jianfei reported to the leadership on the company's groundbreaking advancements in the field of 3D machine vision. ：

I. Breakthrough in Domestic Technological Localization Leveraging independently developed dynamic 3D reconstruction and high-precision recognition algorithms, we address the technical barriers in real-time perception for complex industrial scenarios, enabling self-reliant control over China's core 3D vision technologies.

II. Industrial Application and Implementation : Deeply empowering the high-end equipment manufacturing sector in the cooperation zone, driving the full-chain upgrade of precision component quality inspection, and creating a demonstration scenario for intelligent industrial testing.

3. Bay Area Layout Plan : Strategic layout of the 3D Vision Technology R&D Center, fostering deep collaboration to build a "High-end Equipment R&D Base," and supporting the growth of emerging industrial clusters such as intelligent manufacturing.

After listening to the leader's comments, Xing Jianfei said: "In the future, as more high-end innovation resources converge, Qiyuan Vision will deeply integrate with the industrial needs of the Greater Bay Area, continuously strengthening its role as an 'Innovation Engine' platform. Leveraging 3D machine vision technology as a key driver, the company aims to position the cooperation zone as a global hub for cutting-edge innovation in high-end intelligent equipment. ”